Targeting Macrophage PDE2A Alleviates Sorafenib Cardiotoxicity in Mice and Cellular Models
Inhibiting PDE2A in cardiac macrophages attenuates sorafenib-induced cardiotoxicity in mouse and cell models while preserving anti-tumor efficacy.
Inhibiting PDE2A in cardiac macrophages attenuates sorafenib-induced cardiotoxicity in mouse and cell models while preserving anti-tumor efficacy.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.